Mckinsey order - cder strategic framework and methodology for regulatory science informatics
Ended Awarded Last action
- Contract number
- 75F40118F18013
- Awardee
-
Mckinsey & Company, Inc. Washington D.c. UEI N6JZARL64EW5 Part of Mckinsey & Company, Inc.
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,901,770
Award facts
- Contract value 100% obligated
- $2,901,770.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20993, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$67,118 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $2,968,888 |
About this award
This is a firm fixed-price BPA call order awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Mckinsey & Company, Inc. Washington D.C., a management consulting firm. The order, valued at $2,901,770.23, is for Mckinsey to provide a strategic framework and methodology for regulatory science informatics to the FDA's Center for Drug Evaluation and Research (CDER). The work is being performed in Silver Spring, Maryland. The order was placed under the General Services Administration's Professional Services Schedule (PSS) contract vehicle, which provides agencies flexible access to Mckinsey's advisory services. This is not a set-aside contract. Mckinsey has received over $500 million in federal contracts since 2008, including work supporting COVID-19 response efforts at agencies like the Department of Veterans Affairs and the Defense Health Agency.
Quick answers
Who was awarded contract 75F40118F18013?
75F40118F18013 was awarded to Mckinsey & Company, Inc. Washington D.c. by Food and Drug Administration (Department of Health and Human Services) on August 2, 2018.
How much is contract 75F40118F18013 worth?
The government has obligated $2,901,770 on 75F40118F18013.
Is contract 75F40118F18013 an order under another contract?
Yes. 75F40118F18013 is a BPA call under GS10F0118S-HHSF223201700022B, a blanket purchase agreement, on The Professional Services Schedule (PSS).
Was contract 75F40118F18013 competed?
The extent of competition for 75F40118F18013 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award